Donate
Australian & New Zealand Childrens Haematology/Oncology Group

ANZCHOG Children’s Cancer Clinical Trials Repository

Study Title
Utilizing Response- and Biology-Based Risk Factors to Guide Therapy in Patients with Non-High-Risk Neuroblastoma
Protocol ID
ANBL1232
Disease (Sub Disease)
Ganglioneuroblastoma
Neuroblastoma
Diagnosis Stage
Relapse/refractory
Sponsor
Children's Oncology Group
Collaborators
National Cancer Institute (NCI)
Trial Status
Closed to Recruitment
Study Type
Treatment
Phase
Phase 3
Age Eligibility
up to 18 months
International registry ID's
NCT02176967
Back to Registry
Study Title Utilizing Response- and Biology-Based Risk Factors to Guide Therapy in Patients with Non-High-Risk Neuroblastoma
Protocol ID ANBL1232
Disease (Sub Disease) Ganglioneuroblastoma
Neuroblastoma
Diagnosis Stage Relapse/refractory
Sponsor Children's Oncology Group
Collaborators National Cancer Institute (NCI)
Links https://clinicaltrials.gov/ct2/show/NCT02176967
Trial Status Closed to Recruitment
Trial Open Date 28/07/2014
Study Type Treatment
Phase Phase 3
Age Eligibility up to 18 months
International registry ID's NCT02176967